David J. Marguglio is SVP and Chief Business Officer of Adamis Pharmaceuticals Corp. Currently has a direct ownership of 233,906 shares of ADMP, which is worth approximately $114,613. The most recent transaction as insider was on Mar 18, 2022, when has been sold 11,859 shares (Common Stock) at a price of $0.6 per share, resulting in proceeds of $7,115. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 234K
0% 3M change
0% 12M change
Total Value Held $114,613

David J. Marguglio Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2022
SELL
Open market or private sale
$7,115 $0.6 p/Share
11,859 Reduced 4.83%
233,906 Common Stock
Dec 01 2021
SELL
Open market or private sale
$39,590 $0.78 p/Share
50,757 Reduced 16.4%
258,765 Common Stock
Feb 21 2021
BUY
Exercise of conversion of derivative security
-
22,258 Added 6.71%
309,522 Common Stock
Nov 20 2020
SELL
Open market or private sale
$14,000 $0.4 p/Share
35,000 Reduced 10.86%
287,264 Common Stock
Nov 18 2020
SELL
Open market or private sale
$3,498 $0.41 p/Share
8,532 Reduced 2.58%
322,264 Common Stock
Sep 29 2020
SELL
Open market or private sale
$16,000 $0.8 p/Share
20,000 Reduced 6.09%
308,539 Common Stock
DJM

David J. Marguglio

SVP and Chief Business Officer
San Diego, CA

Track Institutional and Insider Activities on ADMP

Follow Adamis Pharmaceuticals Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADMP shares.

Notify only if

Insider Trading

Get notified when an Adamis Pharmaceuticals Corp insider buys or sells ADMP shares.

Notify only if

News

Receive news related to Adamis Pharmaceuticals Corp

Track Activities on ADMP